Medical iSight
Medical iSight develops the XRAI extended reality surgical cognition platform for Apple Vision Pro, providing 3D visualization and submillimeter tool tracking for minimally invasive procedures. It serves NHS hospitals, leading US medical centers, and private clinics.
- Company typePrivate
- Founded2019
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Medical iSight does
Medical iSight is a privately-held medical technology company founded in 2019 that develops extended reality (XR) software for minimally invasive surgical procedures. The company's flagship platform, XRAI, delivers 3D visualization and real-time, image-based guidance for surgeons, built natively for Apple Vision Pro hardware and supported by proprietary segmentation, soft-tissue deformation, and registration algorithms. The product surface spans XRAIview (DICOM viewer for radiologists), XRAI-Connect (clinical collaboration platform integrating live fluoroscopy, ultrasound, and patient data), XRAI-Neuro (sub-0.5mm catheter tracking for stroke mechanical thrombectomy), XRAI-Gastro (in development with Stanford), and Clinical Connect (remote virtual collaboration). Tool tracking accuracy within 0.5mm and a stated goal of at least 30% improvement in theatre time form the core technical and economic value proposition.
The business generates revenue primarily through enterprise software licensing to hospital systems, with first revenue recorded in 2022 from St George's University Hospital in London. Strategic clinical partners include Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital, Charing Cross Hospital, NYU Langone Health, Mt Sinai, and the private screening clinic Preventicum, which alone has completed 339 revenue-generating cases. The company also distributes XRAIview via the Apple Vision Pro App Store, providing a self-serve channel for individual clinicians. Non-dilutive capital has come from UK government grants (£500K in 2020 and £1.3m from NIHR in 2022), supplementing a $2.5m SAFE/Series A1 round in 2021 and a current $5m Reg D offering.
Medical iSight operates from London with a US legal entity (Medical iSight Corporation) and maintains a deep technology collaboration with NVIDIA — including a feature in CEO Jensen Huang's CES 2025 keynote — while sitting inside Apple's spatial-computing healthcare ecosystem. Regulatory milestones include UKCA Mark registration as a Class 1 Medical Device (2020) and MHRA approval for the first in-human neuro AR study (2022), with two UK patents filed in 2022 and a US/UK provisional filing in 2023 protecting core IP.
Medical iSight firmographics
Firmographics- Name
- Medical iSight
- Legal name
- Medical iSight Corporation
- Website
- https://medicalisight.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medical iSight develops the XRAI extended reality surgical cognition platform for Apple Vision Pro, providing 3D visualization and submillimeter tool tracking for minimally invasive procedures. It serves NHS hospitals, leading US medical centers, and private clinics.
- Ownership category
- akta.pro rank
Medical iSight industry classification
Industry- Product category
- Surgical Visualization Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
- akta.pro secondary industries
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Medical Imaging AI (HDAAAEAH)
Keywords
Where Medical iSight is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Medical iSight business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Software Licensing: Revenue from licensing XRAI software platform to hospitals and healthcare systems for use in surgical procedures. First revenue generated from St George's University Hospital, London.
- Enterprise Software Sales: Direct enterprise sales of XRAI-Connect platform to hospitals for clinical collaboration. Platform built for hospitals and enterprises with advanced multi-user collaboration features.
- Clinical Collaboration Deals: Revenue-generating agreements with medical institutions including NYU Langone collaboration for neuroradiology and private screening clinic visualization software deal.
- Government Grants: Non-dilutive funding from UK government bodies including £500,000 in government grants (2020) and £1.3m NIHR Government grant (2022) for stroke and aneurysm treatment software development.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
Medical iSight product offering
Product offeringCore offering
Medical iSight develops XRAI, an extended reality (XR) surgical cognition platform for minimally invasive procedures. The platform delivers real-time 3D visualization of patient anatomy, submillimeter tool tracking, and image-based guidance for surgeons, with specialized modules for neurointerventional, gastrointestinal, and other vascular procedures. Core products include XRAIview (DICOM viewer for Apple Vision Pro), XRAI-Connect (clinical collaboration platform), and XRAI-Neuro (stroke procedure guidance).
Product overview
Medical iSight is building XRAI, an integrated extended reality (XR) surgical cognition platform for minimally invasive procedures. The platform consists of multiple integrated products: XRAI (the core platform) combines enhanced visibility with context-aware information for surgical decision support; XRAIview is a DICOM viewer built for Apple Vision Pro enabling radiologists to view medical images in 3D volumetric renderings without traditional monitors; XRAI-Connect serves as a clinical collaboration platform integrating audio/video with 3D models, DICOM files, and live medical data streams; XRAI-Neuro provides specialized AR guidance for neurointerventional stroke procedures with submillimetre tracking accuracy; XRAI-Gastro is in development for GI procedures; and Clinical Connect enables remote virtual collaboration for training and consultation. All products leverage computer vision, machine learning, and real-time data integration to improve surgical outcomes.
Differentiator
Problem solved
Functional benefit
Brands
- XRAI: Extended reality surgical cognition platform for minimally invasive procedures. Includes XRAIview (DICOM viewer for Apple Vision Pro), XRAI-Connect (clinical collaboration platform), and XRAI-Neuro (stroke treatment software).
- XRAIview
- XRAI-Connect
- XRAI-Neuro
Products and services
- XRAI Platform Core Extended Reality (XR) surgical cognition platform for minimally invasive procedures, combining enhanced 3D visibility with context-aware information to help surgeons make better-informed decisions in the OR.
- XRAIview DICOM viewer for radiologists and clinicians built for Apple Vision Pro, providing immersive 3D cinematic volumetric renderings and 2D tri-planar views with transfer function controls for highlighting tissues, vessels and lesions.
Quantifiable outcome
- Tool tracking within 0.5mm accuracy
- +3 more outcomes
Companies that use Medical iSight
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Medical iSight technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability8 records
Feature7 records
Medical iSight partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered flagship, core and supporting.
- NVIDIAflagshipDeep collaboration with NVIDIA including attending GTC conferences, CTO Philip Pratt presenting at GTC with best poster award, XRAI-Neuro video featured in Jensen Huang's CES 2025 keynote speech, and joint exhibition at RSNA Conference. NVIDIA's high-performance computing enables Medical iSight's real-time AI inferencing for image segmentation and instrument tracking.
- Imperial College Healthcare NHS TrustcoreMajor NHS strategic partner for XRAI development. Ethics approvals obtained for neuro, GI, and oncoplastics procedures. First procedure (breast reconstruction) completed in 2021. Collaborates on expanding XRAI to multiple surgical specialties.
- NYU Langone HealthcoreNeuroradiology collaboration established January 2023. 4 specialty collaboration signed in 2021. Neuro collaboration progressing with focus on stroke treatment applications.
- Chelsea and Westminster Hospital NHS Foundation TrustcoreFirst NHS deployment of endometriosis visualization tool using Apple Vision Pro. Originally funded by CW+ charity. Piloted in 2025 and now becoming standard practice. First visualization tool of its kind in the NHS.
- St George's Hospital, LondoncoreAgreement signed in 2020 for V1 software to be used for DIEP flap reconstructive surgery. Generated first company revenue. Continued partnership for clinical validation.
- CW+ CharitysupportingHospital's official charity that originally funded the Apple Vision Pro endometriosis visualization program at Chelsea and Westminster Hospital.
- Charing Cross HospitalsupportingAgreement signed for 50-patient study to commence using XRAI software for clinical validation.
- PreventicumsupportingRevenue-generating partnership with private screening clinic. 339 cases completed, demonstrating commercial viability of visualization software.
- ApplecoreXRAIview is built specifically for Apple Vision Pro hardware. Medical iSight is part of Apple's healthcare ecosystem for spatial computing applications in medicine. Platform of choice for XR headset display.
Scale indicators8 records
Recent moves6 records
Expansion highlights8 records
Medical iSight competitors and assessment
Company assessmentDirect peers
- Brainlab: Munich-based surgical navigation and digital OR platform that combines 3D visualization, image guidance, and software for neurosurgery and other specialties — directly overlapping with XRAI-Neuro's positioning in the same neurosurgical navigation workflow.
- Augmedics: Developer of the xvision augmented-reality surgical guidance system for spine surgery, combining headset-based visualization with instrument tracking — a direct peer in AR surgical guidance on different hardware and specialty.
- Medivis: AR/AI surgical visualization company built around Apple Vision Pro and HoloLens, providing 3D anatomical visualization and AI decision support — the closest direct peer in the spatial-computing surgical software category.
- Surgical Theater: VR/AR surgical planning platform that converts patient imaging into immersive 3D environments for pre-operative planning and patient education — comparable use case (DICOM-to-3D visualization) with adjacent technology.
- FundamentalVR: Haptic VR surgical training and visualization platform with multi-user collaboration features — directly comparable in the XR/AR surgical software category and in collaborative remote clinical use cases like XRAI-Connect.
Emerging players
- ImmersiveTouch: VR-based surgical planning and training platform that creates 3D models from patient imaging — partial overlap with XRAIview's DICOM visualization and the training/collaboration use cases of XRAI-Connect.
Broad incumbents
- Medtronic: Owner of StealthStation surgical navigation and a broad portfolio of neurosurgery, spine, and intraoperative imaging products — the dominant incumbent in surgical navigation whose installed base and regulatory depth set the competitive benchmark.
- Stryker: Diversified medical device company with surgical visualization, navigation, and endoscopy franchises (e.g., Mako, SPY imaging) — a broad incumbent that could ship competing AR/AI surgical visualization at scale.
- Siemens Healthineers: Major imaging and surgical solutions incumbent with AI imaging, intraoperative imaging, and digital OR offerings — the kind of well-capitalised incumbent that could rapidly add native Apple Vision Pro visualization to its installed base.
- Philips: Healthcare technology incumbent with image-guided therapy, interventional suites, and clinical collaboration software — competes at the system level in the same hospitals Medical iSight is targeting.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Medical iSight social profiles
Digital presenceMedical iSight compliance and trust
Trust signalCompliance1 record
Medical iSight financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medical iSight leadership team
Management profileNumber of profiles
Profiles5 records
Medical iSight funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medical iSight M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medical iSight
What does Medical iSight do?
Medical iSight develops XRAI, an extended reality (XR) surgical cognition platform for minimally invasive procedures. The platform delivers real-time 3D visualization of patient anatomy, submillimeter tool tracking, and image-based guidance for surgeons, with specialized modules for neurointerventional, gastrointestinal, and other vascular procedures. Core products include XRAIview (DICOM viewer for Apple Vision Pro), XRAI-Connect (clinical collaboration platform), and XRAI-Neuro (stroke procedure guidance).
Is Medical iSight a public or private company?
Medical iSight is a private company. It is classified as venture growth investor backed and is currently operating.
When was Medical iSight founded?
Medical iSight was founded in 2019. It employs 11 to 50 people.
Where is Medical iSight based?
Medical iSight is headquartered in New York, United States, in the North America region.
How does Medical iSight make money?
Four revenue lines are on record. Software Licensing is the primary driver. The others are enterprise Software Sales, clinical Collaboration Deals and government Grants.
Who are Medical iSight's main competitors?
Direct peers on record are Brainlab, Augmedics, Medivis, Surgical Theater and FundamentalVR. ImmersiveTouch is listed as an emerging player. Broad incumbents are Medtronic, Stryker, Siemens Healthineers and Philips.
Does Medical iSight have an API?
No public API is recorded for Medical iSight.
What industry is Medical iSight in?
Medical iSight's product category is Surgical Visualization Software. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 334510 and its SIC code is 3841.